ScripThe flow of venture capital into biopharmaceutical companies has been astonishing – breaking the prior record by a wide margin in 2020 – and, so far, 2021 looks like it is on track to leave a big gap
ScripThe start-up-creating investment firm Flagship Pioneering has combined two companies in its portfolio with complementary technologies into one entity called Repertoire Immune Medicines , which launch
ScripDerived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biophar
ScripThe recent $114m Series B round raised by Semma Therapeutics Inc. reflects two positive trends about the venture capital environment for biopharmaceuticals companies – both the number of companies